400
Participants
Start Date
February 28, 2006
Primary Completion Date
June 30, 2007
Study Completion Date
June 30, 2007
Dasatinib
Tablets, Oral, 70 mg, Twice daily, 2 months.
Local Institution, Corona
Local Institution, Aurora
Local Institution, Colorado Springs
Local Institution, Waterford
Local Institution, Daytona Beach
Local Institution, Jupiter
Local Institution, Atlanta
Local Institution, Lawrenceville
Local Institution, Beach Grove
Local Institution, Indianapolis
Local Institution, Iowa City
Local Institution, Kansas City
Local Institution, Salina
Local Institution, Lexington
Local Institution, Louisville
Local Institution, Boston
Local Institution, Ann Arbor
Local Institution, Detroit
Local Institution, Santa Fe
Local Institution, New York
Local Institution, Cincinnati
Local Institution, Cleveland
Local Institution, Lawton
Local Institution, Tulsa
Local Institution, Portland
Local Institution, Providence
Local Institution, Charleston
Local Institution, Chattanooga
Local Institution, Spokane
Local Institution, Sheboygan
Local Institution, Edmonton
Local Institution, Vancouver
Local Institution, Hamilton
Local Institution, Toronto
Local Institution, Montreal
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY